The coronavirus was declared a global pandemic by the World Health Organization on March 11, 2020. Among the patient groups who were at the highest risk for severe illness were immunocompromised cancer patients. Amid the challenges, COVID-19 presented New York Cancer & Blood Specialists (NYCBS) with an opportunity to demonstrate resilience in the face of change.